Medical Treatment of Adenotonsillar Hypertrophy- Study of 50 cases

Authors

  • MA Matin Professor and Head of the Department of ENT & HNS, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh
  • Md Abul Kalam Azad Associate Professor and Head of Paediatrics, Satkhira Medical College, Satkhira, Bangladesh
  • Masud Bin Hasan Oral and Maxillofacial Surgeon, Sir Salimullah Medical College & Mitford Hospital, Dhaka, Bangladesh
  • Muhammad Mahmudul Haque Deputed to BSMMU, DG Health, Dhaka, Bangladesh
  • Tanjhila Akhter Sir Salimullah Medical College & Mitford Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/bjo.v28i1.60794

Keywords:

Adenotonsillar hypertrophy, intranasal steroid, monteleukast

Abstract

Objective: To examine the efficacy of combined use of intranasal steroids, antibiotics and monteleukast for improving adenotonsillar hypertrophy.

Materials and Methods: This prospective study was done at Bangladesh ENT Hospital, Dhaka from January 2020 to June 2021. 50 children were included with primary symptoms of mouth breathing, snoring and sleep disturbances. X-ray soft tissue nasopharynx lateral view was done before and after treatment for comparison. All were prescribed intranasal fluticasone, phenoxymethyl penicillin and monteleukast for 3 months and followed up after completion of 3 months treatment.

Results: The age of the children ranged from 2-12 years with mean age 5.4 years. There were 30 female and 20 male with female male ratio 3:2. 30 patients (60%) got complete relief of primary symptoms, 12patients (24%) got moderate improvement of symptoms and 8(16%) patients got no benefit of medical treatment and referred for surgery.

Conclusion: Intranasal steroid along with oral penicillin and monteleukast are effective reducing size of adenotonsillar hypertrophy, relieving symptoms and reducing the need for surgery.

Bangladesh J Otorhinolaryngol 2022; 28(1): 16-21

Downloads

Download data is not yet available.
Abstract
416
PDF
548

Downloads

Published

2022-07-20

How to Cite

Matin, M. ., Kalam Azad, M. A. ., Hasan, M. B. ., Haque, M. M. ., & Akhter, T. . (2022). Medical Treatment of Adenotonsillar Hypertrophy- Study of 50 cases. Bangladesh Journal of Otorhinolaryngology, 28(1), 16–21. https://doi.org/10.3329/bjo.v28i1.60794

Issue

Vol. 28 No. 1 (2022)

Section

Original Articles

License

Manuscripts submitted for publication in the Bangladesh Journal of Otorhinolaryngology must not have been previously submitted or published. Accepted papers become the permanent property of the Bangladesh Journal of Otorhinolaryngology. By submitting a manuscript, the authors(s) agree that copyrights for their articles are automatically transferred to Bangladesh Journal of Otorhinolaryngology, if and when the articles are accepted for publication.

The use, in this journal, of registered trade names, trade marks, etc. without special acknowledgement does not imply that such names, as defined by the relevant protection laws, be regarded as unprotected, and, thus, free for general use.

Authors who publish with this journal agree to the following terms:

 

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).